Clinical Trial Update: Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma [NA]

View source ↗

Summary

A pilot study evaluating Pulsed Dye Laser (PDL) for treating facial telangiectasia in systemic sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Pulsed Dye Laser

Snippet

Sponsor: University Hospital, Caen | Conditions: Telangiectasia | NA | Status: COMPLETED